Published in Kidney Int on December 01, 1991
C3a mediates epithelial-to-mesenchymal transition in proteinuric nephropathy. J Am Soc Nephrol (2009) 1.85
Experimental membranous nephropathy redux. Am J Physiol Renal Physiol (2005) 1.52
Identification of membrane-bound CR1 (CD35) in human urine: evidence for its release by glomerular podocytes. J Exp Med (1994) 1.08
Excretion of complement proteins and its activation marker C5b-9 in IgA nephropathy in relation to renal function. BMC Nephrol (2011) 1.08
Complement activation contributes to the injury and outcome of kidney in human anti-glomerular basement membrane disease. J Clin Immunol (2012) 0.93
Eculizumab reduces complement activation, inflammation, endothelial damage, thrombosis, and renal injury markers in aHUS. Blood (2015) 0.90
The membrane attack complex, C5b-9, up regulates collagen gene expression in renal tubular epithelial cells. Clin Exp Immunol (2004) 0.89
An update on 'progression promoters' in renal diseases. J Natl Med Assoc (2003) 0.84
Complement activation in progressive renal disease. World J Nephrol (2015) 0.77
C5b-9 does not mediate tubulointerstitial injury in experimental acute glomerular disease characterized by selective proteinuria. World J Nephrol (2016) 0.75
Complement Component 3 Adapts the Cerebrospinal Fluid for Leptomeningeal Metastasis. Cell (2017) 0.75
Blood pressure control, proteinuria, and the progression of renal disease. The Modification of Diet in Renal Disease Study. Ann Intern Med (1995) 5.50
Primate erythrocyte-immune complex-clearing mechanism. J Clin Invest (1983) 3.57
Rituximab treatment of idiopathic membranous nephropathy. Kidney Int (2007) 2.85
Thiazide diuretic monotherapy for hypertension: diuretic's dark side just got darker. Kidney Int (2007) 2.84
Identifying specific causes of kidney allograft loss. Am J Transplant (2008) 2.77
The histology of solitary renal allografts at 1 and 5 years after transplantation. Am J Transplant (2010) 2.40
Kidney allograft survival after acute rejection, the value of follow-up biopsies. Am J Transplant (2013) 2.35
Cyclosporine in patients with steroid-resistant membranous nephropathy: a randomized trial. Kidney Int (2001) 2.17
Terminal complement inhibition decreases antibody-mediated rejection in sensitized renal transplant recipients. Am J Transplant (2011) 1.98
Complete avoidance of calcineurin inhibitors in renal transplantation: a randomized trial comparing sirolimus and tacrolimus. Am J Transplant (2006) 1.83
A randomized trial of cyclosporine in patients with steroid-resistant focal segmental glomerulosclerosis. North America Nephrotic Syndrome Study Group. Kidney Int (1999) 1.82
The living donor in kidney transplantation. Ann Intern Med (1987) 1.81
Studies of the mechanism by which phosphate infusion lowers serum calcium concentration. J Clin Invest (1966) 1.81
Interaction of rifampin and glucocorticoids. Adverse effect on renal allograft function. JAMA (1976) 1.77
Recurrent idiopathic membranous nephropathy: early diagnosis by protocol biopsies and treatment with anti-CD20 monoclonal antibodies. Am J Transplant (2009) 1.71
Interpreting post-transplant proteinuria in patients with proteinuria pre-transplant. Am J Transplant (2006) 1.70
Serum C3 levels are diagnostically more sensitive and specific for systemic lupus erythematosus activity than are serum C4 levels. The Lupus Nephritis Collaborative Study Group. Am J Kidney Dis (1991) 1.66
Baseline donor-specific antibody levels and outcomes in positive crossmatch kidney transplantation. Am J Transplant (2010) 1.56
Complement depletion accelerates the clearance of immune complexes from the circulation of primates. J Clin Invest (1984) 1.46
Kidney transplant function and histological clearance of virus following diagnosis of polyomavirus-associated nephropathy (PVAN). Am J Transplant (2006) 1.42
Transplant glomerulopathy: subclinical incidence and association with alloantibody. Am J Transplant (2007) 1.40
Renoprotective therapy: how good can it get? Kidney Int (2000) 1.39
Therapy of membranous nephropathy: what to do after the after (meta) analyses. J Am Soc Nephrol (1995) 1.39
CR1 and CR1-like: the primate immune adherence receptors. Immunol Rev (2001) 1.27
Proteinuria after kidney transplantation, relationship to allograft histology and survival. Am J Transplant (2007) 1.25
Clinical practice guidelines for managing dyslipidemias in kidney transplant patients: a report from the Managing Dyslipidemias in Chronic Kidney Disease Work Group of the National Kidney Foundation Kidney Disease Outcomes Quality Initiative. Am J Transplant (2004) 1.23
Glomerular volume and renal histology in obese and non-obese living kidney donors. Kidney Int (2006) 1.23
The complex nature of serum C3 and C4 as biomarkers of lupus renal flare. Lupus (2010) 1.21
Assessment of changes in kidney allograft function using creatinine-based estimates of glomerular filtration rate. Am J Transplant (2007) 1.19
Spot urine protein/creatinine ratios are unreliable estimates of 24 h proteinuria in most systemic lupus erythematosus nephritis flares. Kidney Int (2007) 1.18
Renal artery dissection causing renal infarction in otherwise healthy men. Am J Kidney Dis (1997) 1.17
Electrophysiologic studies in atrial fibrillation. Slow conduction of premature impulses: a possible manifestation of the background for reentry. Am J Cardiol (1983) 1.13
Urine high and low molecular weight proteins one-year post-kidney transplant: relationship to histology and graft survival. Am J Transplant (2013) 1.12
Histologic findings one year after positive crossmatch or ABO blood group incompatible living donor kidney transplantation. Am J Transplant (2006) 1.12
Differential binding of immunoglobulin A and immunoglobulin G1 immune complexes to primate erythrocytes in vivo. Immunoglobulin A immune complexes bind less well to erythrocytes and are preferentially deposited in glomeruli. J Clin Invest (1986) 1.11
5/6 nephrectomy as a validated rat model mimicking human warfarin-related nephropathy. Am J Nephrol (2012) 1.10
Survival of patients on the kidney transplant wait list: relationship to cardiac troponin T. Am J Transplant (2008) 1.07
The erythrocyte-immune complex-glomerulonephritis connection in man. Kidney Int (1987) 1.07
Assessment of disease activity and impending flare in patients with systemic lupus erythematosus. Comparison of the use of complement split products and conventional measurements of complement. Arthritis Rheum (1992) 1.07
Some hemodynamic determinants of immune complex trapping by the kidney. Kidney Int (1978) 1.05
Clearance of human antibody/DNA immune complexes and free DNA from the circulation of the nonhuman primate. Clin Immunol Immunopathol (1987) 1.04
Phenotypes, genotypes and disease susceptibility associated with gene copy number variations: complement C4 CNVs in European American healthy subjects and those with systemic lupus erythematosus. Cytogenet Genome Res (2009) 1.03
Complement activation induces the expression of decay-accelerating factor on human mesangial cells. J Immunol (1991) 1.02
Remission of nephrotic syndrome in type 1 diabetes: long-term follow-up of patients in the Captopril Study. Am J Kidney Dis (1999) 1.02
Tumor-associated blocking factors: isolation from sera of tumor-bearing mice. J Immunol (1976) 1.00
Effects of high glucose on cellular proliferation and fibronectin production by cultured human mesangial cells. Kidney Int (1992) 1.00
Diagnostic significance of hypocomplementemia. Kidney Int (1991) 0.97
Interactions between precipitating and nonprecipitating antibodies in the formation of immune complexes. J Immunol (1987) 0.97
Radiofrequency catheter ablation for the treatment of human type 1 atrial flutter. Circulation (1993) 0.97
Measurement of the fractional uptake of macromolecules by the renal vascular bed compared to other vascular beds. J Lab Clin Med (1976) 0.97
Loin pain-hematuria syndrome associated with thin glomerular basement membrane disease and hemorrhage into renal tubules. Kidney Int (1996) 0.96
Protocol biopsies in renal transplantation: insights into patient management and pathogenesis. Am J Transplant (2007) 0.96
Evaluation of the mechanisms responsible for the reduction in erythrocyte complement receptors when immune complexes form in vivo in primates. J Immunol (1990) 0.95
Soluble immune complexes binding to human monocytes and polymorphonuclear leucocytes. Immunology (1981) 0.95
The pathology and clinical features of early recurrent membranous glomerulonephritis. Am J Transplant (2012) 0.93
Mycophenolate mofetil therapy in lupus nephritis: clinical observations. J Am Soc Nephrol (1999) 0.93
Combination ACE inhibitor and angiotensin II receptor antagonist therapy in diabetic nephropathy. Am J Nephrol (1999) 0.93
Activation of the alternative complement pathway accompanies disease flares in systemic lupus erythematosus during pregnancy. Arthritis Rheum (1992) 0.92
Consumption of erythrocyte CR1 (CD35) is associated with protection against systemic lupus erythematosus renal flare. Clin Exp Immunol (2006) 0.92
Recurrent idiopathic membranous nephropathy after kidney transplantation: a surveillance biopsy study. Am J Transplant (2008) 0.92
Severe renal failure in multiple myeloma. Clin Nephrol (1981) 0.92
Obese living kidney donors: short-term results and possible implications. Transplantation (1999) 0.92
Vitamin D deficiency as marker for disease activity and damage in systemic lupus erythematosus: a comparison with anti-dsDNA and anti-C1q. Lupus (2011) 0.92
Fragmented electrograms and continuous electrical activity in atrial flutter. Am J Cardiol (1986) 0.92
Subacute bacterial endocarditis masquerading as type III essential mixed cryoglobulinemia. J Am Soc Nephrol (1997) 0.91
Characterization of the baboon erythrocyte C3b-binding protein. J Immunol (1989) 0.91
Human fibronectin is an opsonin for IgG antibody-coated sheep erythrocytes. J Lab Clin Med (1984) 0.90
Factors influencing the binding of large immune complexes to the primate erythrocyte CR1 receptor. Clin Immunol Immunopathol (1984) 0.90
Atheroembolic renal disease causes hypocomplementaemia. Lancet (1985) 0.89
Living donor age and kidney transplant outcomes. Am J Transplant (2011) 0.88
Binding of human fibronectin to antigen-antibody complexes. J Lab Clin Med (1986) 0.88
Kidney allograft inflammation and fibrosis, causes and consequences. Am J Transplant (2012) 0.86
Posttransplant lymphoproliferative disorder following pancreas transplantation. Am J Transplant (2009) 0.86
Onset of atrial fibrillation during antidromic tachycardia: association with sudden cardiac arrest and ventricular fibrillation in a patient with Wolff-Parkinson-White syndrome. Am J Cardiol (1982) 0.86
Progressive histologic injury in kidneys from heart and liver transplant recipients receiving cyclosporine. Transplantation (1996) 0.86
Transcutaneous oxygen tension in patients with calciphylaxis. Am J Kidney Dis (2001) 0.86
Immune regulation of immunoglobulin production in IgA-nephropathy. Clin Immunol Immunopathol (1982) 0.85
Severity of alcohol withdrawal symptoms and the T1128C polymorphism of the neuropeptide Y gene. J Neural Transm (Vienna) (2002) 0.85
Anti-phospholipase A₂ receptor antibodies in recurrent membranous nephropathy. Am J Transplant (2015) 0.85
Evidence that abnormally large seasonal declines in vitamin D status may trigger SLE flare in non-African Americans. Lupus (2012) 0.85
Immune complexes bind preferentially to specific subpopulations of human erythrocytes. Clin Immunol Immunopathol (1990) 0.85
Pneumococcal vaccination in patients with chronic renal disease and renal allograft recipients. Kidney Int (1981) 0.84
Immune complex erythrocyte complement receptor interactions in vivo during induction of glomerulonephritis in nonhuman primates. J Lab Clin Med (1990) 0.84
Combined nephrotoxic effects of cyclosporine and endotoxin. Transplantation (1987) 0.84
Plasma concentrations of the natural anticoagulants protein C and protein S in patients with proteinuria. J Lab Clin Med (1985) 0.83
Patient survival after kidney transplantation: relationship to pretransplant cardiac troponin T levels. Am J Transplant (2009) 0.83
Pneumatic compression with foot pumps facilitates early postoperative mobilisation in total knee arthroplasty. Int Orthop (2010) 0.83
Polyomavirus-associated nephropathy risk in kidney transplants: the influence of recipient age and donor gender. Kidney Int (2007) 0.83
Binding of soluble immune complexes by human monocytes and pulmonary macrophages: effects of cigarette smoking. J Lab Clin Med (1982) 0.83
Of mice and men: the relevance of the mouse to the study of human SLE. Immunol Res (2001) 0.83
Reversal of chronic end-stage renal failure due to myeloma kidney. Ann Intern Med (1979) 0.83
The outcome of patients with nephrogenic systemic fibrosis after successful kidney transplantation. Am J Transplant (2010) 0.83
DNA binding of activator protein-1 is increased in human mesangial cells cultured in high glucose concentrations. Kidney Int (1998) 0.83
Rapidly progressive glomerulonephritis superimposed on diabetic glomerulosclerosis. Recognition and treatment. JAMA (1982) 0.82